CD274 and neoplasm: A composite predictor that also includes other critical variables, such as PD-L1 IHC, immune-related mutational and epigenetic landscapes as well as gene expression signatures, MHC and T cell receptor repertoire, clonality of neoantigens and tumor heterogeneity, is urgently needed [33,38].